Compare SVM & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVM | AORT |
|---|---|---|
| Founded | N/A | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.4B |
| IPO Year | 2005 | 1996 |
| Metric | SVM | AORT |
|---|---|---|
| Price | $12.13 | $24.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $10.50 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 2.2M | 597.7K |
| Earning Date | 05-25-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $36.87 | $14.20 |
| Revenue Next Year | $35.34 | $11.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $5.00 | $19.16 |
| 52 Week High | $15.77 | $48.25 |
| Indicator | SVM | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 36.23 |
| Support Level | $11.53 | $22.83 |
| Resistance Level | $13.31 | $25.38 |
| Average True Range (ATR) | 0.58 | 1.03 |
| MACD | -0.13 | -0.38 |
| Stochastic Oscillator | 16.53 | 3.08 |
Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.